Kaye Biotech Inc. had the following equity account balances at December 31, 2019: $ 42,700 Preferred shares, $3.00, non-cumulative, Authorizedt 22,200 shares Issued and outstanding: 6,100 shares Common shares, Authorized: Unlimited Issued and outstanding: 90,500 shares Retained earnings 306,311 45,000 On February 1, 2020, 6100 preferred shares were issued at $8.80 each. The board of directors declared and paid the annual cash dividend on the preferred shares on June 30, 2020, and a 14% common share dividend was declared and distributed on the same day when the market price per common share was $4.75. On October 1, 2020, 22,200 common shares were issued at $4.89 each. Profit earned during 2020 was $419,800. Required: Using the information provided, prepare the statement of changes in equity for the year ended December 31, 2020. (Amounts to be deducted should be indicated by a minus sign.) KAYE BIOTECH INC Statement of Changes in Equity For Yoar Ended December 31, 2020 Preferred Common Shorea Shares Retained Earnings Total Equity $ 0 Balance, January 1 0 0 0 0 0 0 Balance, December 31 $ 0 $ 0 $ OS